Education
About Us
Working with TipRanks
Follow Us
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
BTAI Analyst Ratings
Moderate Buy
2 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BTAI Stock 12 Month Forecast
Average Price Target
$8.00
▲(400.00% Upside)
| Highest Price Target$17.00 | Average Price Target$8.00 | Lowest Price Target$1.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Rodman & Renshaw
$17
Buy
962.50%
Upside
Initiated
03/17/26
H.C. Wainwright
$6
Buy
275.00%
Upside
Assigned
03/06/26
Bank of America Securities
$1
Sell
-37.50%
Downside
Reiterated
03/06/26
Mizuho Securities
$4
Hold
150.00%
Upside
Reiterated
09/16/25
Canaccord Genuity
$18
Buy
1025.00%
Upside
Reiterated
09/05/25
Lucid Capital
―
Buy
―
Reiterated
07/15/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Rodman & Renshaw
$17
Buy
962.50%
Upside
Initiated
03/17/26
H.C. Wainwright
$6
Buy
275.00%
Upside
Assigned
03/06/26
Bank of America Securities
$1
Sell
-37.50%
Downside
Reiterated
03/06/26
Mizuho Securities
$4
Hold
150.00%
Upside
Reiterated
09/16/25
Canaccord Genuity
$18
Buy
1025.00%
Upside
Reiterated
09/05/25
Lucid Capital
―
Buy
―
Reiterated
07/15/25
Best Analysts Covering Bioxcel Therapeutics
3 Months
xxx
Success Rate
13/42 ratings generated profit
Average Return
+2.86%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 30.95% of your transactions generating a profit, with an average return of +2.86% per trade.
1 Year
Success Rate
12/42 ratings generated profit
Average Return
+28.61%
reiterated a buy rating 7 months ago
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of +28.61% per trade.
2 Years
xxx
Success Rate
10/42 ratings generated profit
Average Return
+28.20%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.81% of your transactions generating a profit, with an average return of +28.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BTAI Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
5
2
0
0
2
Buy
0
0
0
0
0
Hold
2
1
16
20
19
Sell
1
1
9
10
11
Strong Sell
1
0
1
1
1
total
9
4
26
31
33
Each month's total comprises the sum of three months' worth of ratings.
BTAI Financial Forecast
BTAI Stock Forecast FAQ
What is BTAI’s average 12-month price target, according to analysts?
Based on analyst ratings, Bioxcel Therapeutics Inc’s 12-month average price target is 8.00.
What is BTAI’s upside potential, based on the analysts’ average price target?
Bioxcel Therapeutics Inc has 400.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BTAI a Buy, Sell or Hold?
Bioxcel Therapeutics Inc has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 1 sell ratings.
What is Bioxcel Therapeutics Inc’s price target?
The average price target for Bioxcel Therapeutics Inc is 8.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $17.00 ,the lowest forecast is $1.00. The average price target represents 400.00% Increase from the current price of $1.6.
The highest analyst price target is $17.00 ,the lowest forecast is $1.00. The average price target represents 400.00% Increase from the current price of $1.6.
What do analysts say about Bioxcel Therapeutics Inc?
Bioxcel Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of BTAI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.